Physiotherapy and Therapeutic Exercise Program in Graft-versus-host Disease (GvHD)

Effects of a Physical Therapy and Therapeutic Exercise Program in Graft-versus-host Disease (GVHD)

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05401955

Enrollment

Registered

2022-06-02

Start date

2022-05-01

Completion date

2023-07-30

Last updated

2022-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GVHD,Acute, GVHD, Chronic

Brief summary

Range of motion, antropometric measurements, quality of life questionnaire and 2 minutes walk test will be implemented as an initial assessment. Physical exercise program will take 2 sessions a week for six months, and several follow-ups: before, during and after treatment.

Interventions

OTHERPhysical exercise

An adapted physical exercise protocol

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Allogenic Transplantation patients with Graft versus host disease

Exclusion criteria

* Cognitive impairment * Physical limitation from other pathologies

Design outcomes

Primary

Measure	Time frame	Description
SF36 Questionnaire	baseline and post-intervention (24 weeks)	Quality of life
2 minutes walk test	baseline and post-intervention (24 weeks)	walking for 2 minutes without rest
Hands strength	baseline and post-intervention (24 weeks)	Dynamometer
Active range of motion	baseline and post-intervention (24 weeks)	P-ROM. Active ROM will be compared with standard pictures (1-4 points for lower limb and 1-7 points for upper limb)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026